László Gopcsa - Infectious Diseases

Author Information

Laszló Gopcsa is affiliated with the Department of Hematology and Stem Cell Transplantation at the Central Hospital of Southern-Pest, National Institute of Hematology and Infectious Diseases located in Budapest, Hungary. His work primarily revolves around infectious diseases, hematology, and related fields, with a particular focus on clinical research and treatment methodologies.

Research Contributions

Laszló Gopcsa has extensively contributed to the understanding and treatment of various conditions, including COVID-19, monoclonal gammopathy, and acute myeloid leukemia. His research work is notable for exploring the implications of hematological factors such as the von Willebrand Factor and ADAMTS13 activity in COVID-19 patients, and the ocular comorbidities associated with monoclonal gammopathy. Furthermore, Gopcsa's studies have also investigated therapeutic interventions in severe cytokine release syndrome and the efficacy of treatments like brentuximab vedotin in Hodgkin lymphoma.

Aliases

The author is also known by the names L Gopcsa, L. Gopcsa, Laszló Gopcsa, and László Gopcsa.

Publication and Citation Metrics

Metric	Value
Total Publications	56
Total Citations	464
H-index	12

Publications:

Associations between the von Willebrand Factor—ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality

DOI: 10.1055/s-0041-1740182

Year: 2022

Corneal Densitometry and In Vivo Confocal Microscopy in Patients with Monoclonal Gammopathy—Analysis of 130 Eyes of 65 Subjects

DOI: 10.3390/jcm11071848

Year: 2022

Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia

DOI: 10.1371/journal.pone.0253386

Year: 2021

Ocular Signs and Ocular Comorbidities in Monoclonal Gammopathy: Analysis of 80 Subjects

DOI: 10.1155/2021/9982875

Year: 2021

Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients

DOI: 10.1055/s-0041-1728127

Year: 2021

Ocular signs and comorbidities in monoclonal gammopathy: Analysis of 84 eyes of 42 subjects

DOI: 10.1556/650.2021.32228

Year: 2021

Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection

DOI: 10.3389/fimmu.2021.663187

Year: 2021

Common points of therapeutic intervention in COVID-19 and in allogeneic hematopoietic stem cell transplantation associated severe cytokine release syndrome.

DOI: 10.1556/030.2021.01620

Year: 2021

Laboratory parameters predicting mortality of adult in-patients with COVID-19 associated cytokine release syndrome treated with high-dose tocilizumab.

DOI: 10.1556/030.2021.01526

Year: 2021

Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma

DOI: 10.1007/s00277-020-04204-1

Year: 2020

What Research is Being Conducted?

Are There Any Concerns About Drug Resistance?

How do Pathogens Use Receptors?

What Role Do Respiratory Droplets Play in Super-Spreading Events?

What is Quarantine?

What are Immunodeficiency Disorders?

What is the Role of Centers for Disease Control and Prevention?

What Challenges Exist in Measles Control?

How Do Insect Repellents Work?

What are Isoprenoids?

Partnered Content Networks

Relevant Topics